The number of people with susceptibility test result for rifampicin in Malaysia
Malaysia: The number of people with susceptibility test result for rifampicin was 10,434 in 2021. ▼ Falling
Latest (2021)
10,434
Change on year
up 1.0%
World rank
20th
of 155 countries
All-time high
12,019
in 2019
All-time low
10,328
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Malaysia, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Malaysia recorded 10,434 for the number of people with susceptibility test result for rifampicin in 2021.
The figure is up 1.0% on the previous year and down 8.2% over five years.
That places Malaysia 20th out of 155 countries with data for 2021, putting it in the top quarter.
The number of people with susceptibility test result for rifampicin in Malaysia, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 11,360 | — |
| 2018 | 11,480 | +1.1% |
| 2019 | 12,019 | +4.7% |
| 2020 | 10,328 | -14.1% |
| 2021 | 10,434 | +1.0% |
Malaysia compared with similar countries
- Malaysia's 10,434 is above the median for upper middle income countries, which is 880, 11.9× the median. (46 countries reporting)
- Malaysia's 10,434 is above the median for East Asia & Pacific, which is 185, 56.4× the median. (28 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 11,620 | 11,360 | 12,019 | 3 |
| 2020s | 10,381 | 10,328 | 10,434 | 2 |
Countries ranked near Malaysia
More health data for Malaysia
- Un projection of annual infant deaths, annual growth rate -0.9119 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.2888 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,250 deaths per 1,000 people (2090)
- Number of infants who die before age 1 652 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 18 (2025)
- Population ages 00-04, female, annual growth rate -0.7207 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0297 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.5991 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Malaysia?
- The number of people with susceptibility test result for rifampicin in Malaysia was 10,434 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Malaysia?
- The highest recorded value was 12,019 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Malaysia?
- The lowest recorded value was 10,328 in 2020.
- How does Malaysia rank for the number of people with susceptibility test result for rifampicin?
- Malaysia ranks 20th out of 155 countries with data for 2021.
- Where does this Malaysia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).